ZA956165B - Opthalmic preparation for use as artificial tear - Google Patents

Opthalmic preparation for use as artificial tear

Info

Publication number
ZA956165B
ZA956165B ZA956165A ZA956165A ZA956165B ZA 956165 B ZA956165 B ZA 956165B ZA 956165 A ZA956165 A ZA 956165A ZA 956165 A ZA956165 A ZA 956165A ZA 956165 B ZA956165 B ZA 956165B
Authority
ZA
South Africa
Prior art keywords
mmol
ion
artificial tear
treatment
weight
Prior art date
Application number
ZA956165A
Other languages
English (en)
Inventor
Amalio Cantoro
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of ZA956165B publication Critical patent/ZA956165B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
ZA956165A 1994-07-25 1995-07-25 Opthalmic preparation for use as artificial tear ZA956165B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940485A IT1273011B (it) 1994-07-25 1994-07-25 Preparato oftalmico per l'uso come lacrima artificiale

Publications (1)

Publication Number Publication Date
ZA956165B true ZA956165B (en) 1996-03-07

Family

ID=11402665

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956165A ZA956165B (en) 1994-07-25 1995-07-25 Opthalmic preparation for use as artificial tear

Country Status (15)

Country Link
US (1) US5770628A (ko)
EP (1) EP0698388B1 (ko)
JP (1) JP3795105B2 (ko)
KR (1) KR100444727B1 (ko)
AT (1) ATE187637T1 (ko)
CA (1) CA2154533C (ko)
CZ (1) CZ287223B6 (ko)
DE (1) DE69513902T2 (ko)
DK (1) DK0698388T3 (ko)
ES (1) ES2142976T3 (ko)
GR (1) GR3032958T3 (ko)
IT (1) IT1273011B (ko)
PL (1) PL180836B1 (ko)
PT (1) PT698388E (ko)
ZA (1) ZA956165B (ko)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742336B1 (fr) * 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
DE19910654C2 (de) * 1998-09-07 2000-12-07 Univ Leipzig Infusionslösung für die Makulachirurgie
IT1306123B1 (it) * 1999-04-02 2001-05-30 Technopharma Sa Soluzione oftalmica viscosizzata con azione detergente sulle lenti acontatto.
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
US6716970B2 (en) * 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US20050080043A1 (en) * 2000-09-20 2005-04-14 Lee Shahinian Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
AU2002232437A1 (en) * 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
US6878694B2 (en) * 2000-12-20 2005-04-12 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
IL165910A0 (en) * 2002-07-03 2006-01-15 Pericor Science Inc Compositions of hyaluronic acid and methods of use
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
US6828356B2 (en) * 2002-07-29 2004-12-07 Ast Products, Inc. Preparation of ophthalmic compositions
ITMI20022353A1 (it) * 2002-11-06 2004-05-07 Farmaceutici S R L Composizione di un preparato per gli occhi con attivita' antiallergica, antibatterica e disarrossante.
FR2849383B1 (fr) 2002-12-26 2005-09-30 Jean Noel Thorel Composition trophique en milieu aqueux, et ses applications, notamment en ophtalmologie
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
JPWO2005082384A1 (ja) * 2004-02-27 2008-03-06 株式会社日本トリム 人工生理的塩類溶液およびその製造方法
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
FR2871059B1 (fr) * 2004-06-03 2007-01-05 Oreal Composition artificielle de type fluide lacrymal et son utilisation.
EP2147686A1 (en) * 2004-10-01 2010-01-27 Menicon Co., Ltd. Method for packaging contact lenses
WO2006085351A1 (en) * 2005-02-09 2006-08-17 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
BRPI0714587A2 (pt) * 2006-07-25 2013-05-07 Osmotica Corp suluÇço oftÁlmica aquosa e uso da nesna
US20080153908A1 (en) * 2006-12-20 2008-06-26 Jani Dharmendra M Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
US9579341B2 (en) 2007-05-16 2017-02-28 Johnson & Johnson Consumer Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US8609634B2 (en) * 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
AU2008310956B2 (en) * 2007-10-08 2014-08-07 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US20100203165A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
IT1394223B1 (it) 2009-05-15 2012-06-01 Thea Sas Lab Kit per la valutazione e la selezione personalizzata di lacrime artificiali
CN102458370A (zh) * 2009-06-09 2012-05-16 卢克斯生物科技公司 用于眼科用途的表面药物递送系统
EP2442812A1 (en) 2009-06-19 2012-04-25 Altos Vision Limited Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
US8283463B2 (en) 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
JP4644305B1 (ja) * 2010-05-12 2011-03-02 喜美雄 川村 点眼薬及びその製造方法
AT511164A1 (de) 2011-03-03 2012-09-15 Croma Pharma Gmbh Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
KR101134340B1 (ko) * 2011-06-10 2012-04-09 주식회사 휴온스 안과질환 예방 또는 치료용 점안제 조성물
FR2986703B1 (fr) 2012-02-09 2015-01-16 Horus Pharma Dispositif de conditionnement et de distribution d'un produit a usage ophtalmique
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
WO2016104705A1 (ja) 2014-12-26 2016-06-30 生化学工業株式会社 眼の自覚症状を改善する剤および方法
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
ITUB20152542A1 (it) 2015-07-28 2017-01-28 Altergon Sa Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US10561682B1 (en) * 2019-04-01 2020-02-18 Judith Boston Treatment of ischemic conditions, hypoxic conditions, conditions related to a hypoxia-induction factor, or conditions related to reactive oxygen species with oxygen-containing liquids
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
WO1984004681A1 (en) 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
CA1263606A (en) 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
EP0323522A4 (en) * 1987-07-07 1989-08-30 Santen Pharmaceutical Co Ltd ARTIFICIAL TEAR.
DE69017559T3 (de) * 1989-07-24 2002-06-06 Allergan Pharmaceuticals Irela Stabile Lösung von Hyaluronat in einem isotonen Salzmilieu.
JP2887485B2 (ja) 1989-08-09 1999-04-26 花王株式会社 油性化粧料

Also Published As

Publication number Publication date
CA2154533C (en) 2007-01-16
ES2142976T3 (es) 2000-05-01
DK0698388T3 (da) 2000-05-08
CZ287223B6 (en) 2000-10-11
JPH08169835A (ja) 1996-07-02
ITRM940485A1 (it) 1996-01-25
CZ191395A3 (en) 1996-02-14
EP0698388B1 (en) 1999-12-15
IT1273011B (it) 1997-07-01
PT698388E (pt) 2000-05-31
US5770628A (en) 1998-06-23
KR960003731A (ko) 1996-02-23
JP3795105B2 (ja) 2006-07-12
DE69513902T2 (de) 2000-05-18
PL309753A1 (en) 1996-02-05
DE69513902D1 (de) 2000-01-20
ITRM940485A0 (it) 1994-07-25
KR100444727B1 (ko) 2006-03-30
ATE187637T1 (de) 2000-01-15
CA2154533A1 (en) 1996-01-26
GR3032958T3 (en) 2000-07-31
PL180836B1 (pl) 2001-04-30
EP0698388A1 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
ZA956165B (en) Opthalmic preparation for use as artificial tear
DE69917040D1 (de) Augenlösung mit tetracyclin für behandlung von trockenen augen
SE8703972D0 (sv) Ogondroppar
CA2059403A1 (en) Use of Carrageenans in Topical Ophthalmic Compositions
DE68927631T2 (de) Wässrige Augenlösung und Verfahren zur Konservierung derselben
DE3682117D1 (de) Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung.
AU656385B2 (en) Methods and compositions for inhibiting deposit formation on contact lenses
EP0381617A3 (en) Disinfecting and cleaning composition for contact lenses
US6194457B1 (en) Liquid eye drop composition
SI0875248T1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
AU591484B2 (en) Ophthalmic solutions and methods for improving the comfort and safety of contact lenses
WO1991017469A1 (en) Kit for contact lenses
JO1317B1 (en) Eye treatment
CA2086188A1 (en) Use of hyaluronic acid as ocular prosthesis lubricant